Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
etoposide dna topoisomerase 2-alpha small molecule NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Myeloid Leukemia[MeSHID:D007951]
Lymphoma[MeSHID:D008223]
Small cell carcinoma of lung[MeSHID:D055752]
Testicular Neoplasms[MeSHID:D013736]
Glioblastoma[MeSHID:D005909]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.89 approved inhibitor
etoposide dna topoisomerase 2-alpha small molecule NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Myeloid Leukemia[MeSHID:D007951]
Lymphoma[MeSHID:D008223]
Small cell carcinoma of lung[MeSHID:D055752]
Testicular Neoplasms[MeSHID:D013736]
Glioblastoma[MeSHID:D005909]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Malignant neoplasm of testis[MeSHID:D013736]
Disease[MeSHID:D004194]		 0.89 approved inhibitor
etoposide dna topoisomerase 2-beta small molecule NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Myeloid Leukemia[MeSHID:D007951]
Lymphoma[MeSHID:D008223]
Small cell carcinoma of lung[MeSHID:D055752]
Testicular Neoplasms[MeSHID:D013736]
Glioblastoma[MeSHID:D005909]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]		 0.23 approved inhibitor
etoposide dna topoisomerase 2-beta small molecule NA drugbank , DGIDB Malignant Neoplasms[MeSHID:D009369]
Myeloid Leukemia[MeSHID:D007951]
Lymphoma[MeSHID:D008223]
Small cell carcinoma of lung[MeSHID:D055752]
Testicular Neoplasms[MeSHID:D013736]
Glioblastoma[MeSHID:D005909]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Coronavirus Infections[MeSHID:D018352]
Malignant neoplasm of testis[MeSHID:D013736]
Disease[MeSHID:D004194]		 0.23 approved inhibitor
click here to return to the previous page